Jinfeng Ning
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Oxidative stress-driven m5C methylation by NSUN5 confers cisplatin resistance in lung adenocarcinoma through promoting glycolysis.
Journal: Redox biology
Published: March 22, 2026
G protein-coupled receptor 87 promotes lung adenocarcinoma progression and metastasis via a histone lactylation-driven glycolytic feed-forward circuit.
Journal: Free radical biology & medicine
Published: March 19, 2026
FTO-mediated m6A modification of QPCT promotes tumorigenesis in lung adenocarcinoma by inducing macrophage chemotaxis and M2 polarization.
Journal: American journal of cancer research
Published: September 07, 2024
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma.
Journal: Cancer cell international
Published: February 16, 2024
A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
Journal: Frontiers in oncology
Published: June 21, 2022
Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.
Journal: Cell death discovery
Published: March 17, 2022
A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma.
Journal: Frontiers in genetics
Published: March 07, 2022
Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC.
Journal: Frontiers in genetics
Published: September 18, 2021
Surgical Trauma-induced CCL2 Upregulation Mediates Lung Cancer Progression by Promoting Treg Recruitment in Mice and Patients.
Journal: Cancer investigation
Published: September 13, 2021
Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.
Journal: Cell death & disease
Published: August 09, 2021
YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.
Journal: Cells
Published: April 26, 2021
Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Journal: Cell death & disease
Published: December 31, 2020
Last Updated: 09/26/2026